Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 4/20 | 0.72 |
| ▸ | RAB9A | P51151 | 4/20 | 0.72 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.72 |
| ▸ | TP53 | P04637 | 2/20 | 0.72 |
| ▸ | CASP1 | P29466 | 2/20 | 0.72 |
| ▸ | MAPK10 | P53779 | 2/20 | 0.72 |
| ▸ | CASP7 | P55210 | 2/20 | 0.72 |
| ▸ | POLB | P06746 | 2/20 | 0.72 |
| ▸ | MAPT | P10636 | 8/20 | 0.66 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.66 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.66 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.66 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.66 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.66 |
| ▸ | PLK4 | O00444 | 1/20 | 0.52 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.52 |
| ▸ | AURKA | O14965 | 1/20 | 0.52 |
| ▸ | DAPK3 | O43293 | 1/20 | 0.52 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.52 |
| ▸ | CDK1 | P06493 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18808809 | 0.90 | NPC1 (0.62) | NPC1RAB9ASMN1; SMN2TP53CASP1 | |
| SCHEMBL278729 | 0.84 | RAB9A (1.00) | NPC1RAB9ASMN1; SMN2TP53CASP1 | |
| SCHEMBL29572859 | 0.84 | RAB9A (1.00) | NPC1RAB9ASMN1; SMN2TP53CASP1 | |
| SCHEMBL9436882 | 0.83 | NPC1 (0.72) | NPC1RAB9ASMN1; SMN2TP53CASP1 | |
| SCHEMBL9706302 | 0.80 | NPC1 (0.61) | NPC1RAB9ASMN1; SMN2TP53CASP1 | |
| SCHEMBL8832011 | 0.80 | NPC1 (0.71) | NPC1RAB9ASMN1; SMN2TP53CASP1 | |
| SCHEMBL8832035 | 0.80 | NPC1 (0.71) | NPC1RAB9ASMN1; SMN2TP53CASP1 | |
| SCHEMBL9706263 | 0.75 | CASP1 (0.65) | NPC1RAB9ASMN1; SMN2TP53CASP1 | |
| SCHEMBL3257675 | 0.75 | MAPK9 (0.70) | NPC1RAB9ASMN1; SMN2TP53CASP1 | |
| SCHEMBL824397 | 0.74 | SMN1; SMN2 (0.73) | NPC1RAB9ASMN1; SMN2TP53CASP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10988810-B2 | Methods and materials for detection of mutations | PENTABASE APS (DK) | 2021-04-27 | — | — | US | disclosed |
| US-20190085400-A1 | METHODS AND MATERIALS FOR DETECTION OF MUTATIONS | PENTABASE APS (DK) | 2019-03-21 | — | — | US | disclosed |
| WO-2017045689-A1 | METHODS AND MATERIALS FOR DETECTION OF MUTATIONS | PENTABASE APS (DK) | 2017-03-23 | — | — | WO | disclosed |
| US-8133984-B2 | Oligonucleotides comprising signalling pairs and hydrophobic nucleotides, stemless beacons, for detection of nucleic acids, methylation status and mutants of nucleic acids | PENTABASE APS (DK) | 2012-03-13 | — | — | US | disclosed |
| US-8133984-B2 | Oligonucleotides comprising signalling pairs and hydrophobic nucleotides, stemless beacons, for detection of nucleic acids, methylation status and mutants of nucleic acids | PENTABASE APS (DK) | 2012-03-13 | — | — | US | disclosed |
| US-20100121056-A1 | PSEUDONUCLEOTIDE COMPRISING AN INTERCALATOR | HUMAN GENETIC SIGNATURES PTY. LTD. (AU) | 2010-05-13 | — | — | US | disclosed |
| US-20100121056-A1 | PSEUDONUCLEOTIDE COMPRISING AN INTERCALATOR | HUMAN GENETIC SIGNATURES PTY. LTD. (AU) | 2010-05-13 | — | — | US | disclosed |
| US-20100068704-A1 | OLIGONUCLEOTIDES COMPRISING SIGNALLING PAIRS AND HYDROPHOBIC NUCLEOTIDES, STEMLESS BEACONS, FOR DETECTION OF NUCLEIC ACIDS, METHYLATION STATUS AND MUTANTS OF NUCLEIC ACIDS | PENTABASE APS (DK) | 2010-03-18 | — | — | US | disclosed |
| US-20100068704-A1 | OLIGONUCLEOTIDES COMPRISING SIGNALLING PAIRS AND HYDROPHOBIC NUCLEOTIDES, STEMLESS BEACONS, FOR DETECTION OF NUCLEIC ACIDS, METHYLATION STATUS AND MUTANTS OF NUCLEIC ACIDS | PENTABASE APS (DK) | 2010-03-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100068704-A1 | OLIGONUCLEOTIDES COMPRISING SIGNALLING PAIRS AND HYDROPHOBIC NUCLEOTIDES, STEMLESS BEACONS, FOR DETECTION OF NUCLEIC ACIDS, METHYLATION STATUS AND MUTANTS OF NUCLEIC ACIDS | DNMT1, DNMT3A, DNMT3L | NPC1 1858/4885RAB9A 3662/4885SMN1; SMN2 2134/4885 |
| US-20100121056-A1 | PSEUDONUCLEOTIDE COMPRISING AN INTERCALATOR | POLRMT, POLN, RNASE1 | NPC1 1807/4885RAB9A 4419/4885SMN1; SMN2 3710/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.